| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 336.162.320 $ | +58.258.136 $ | +78,7 % | 10 | 313.309.201 $ | +88.364.803 $ | +58,3 % | 9 | 220.997.992 $ | +78.001.017 $ | +30,6 % | 6 | ||||
| STRYKER CORP | SYK | → 0 | Schwach | 50.856.203 $ | +13.785.959 $ | +37,2 % | 1 | 37.070.244 $ | +13.371.440 $ | +56,4 % | 1 | ||||
| INVESCO QQQ TRUST, SERIES 1 | QQQ | → 0 | 48.029.600 $ | +48.029.600 $ | 1 | ||||||||||
| BOSTON SCIENTIFIC CORP | BSX | → 0 | Neutral | 28.160.192 $ | -19.565.248 $ | -41,0 % | 1 | 47.725.440 $ | +5.317.213 $ | +12,5 % | 1 | 42.408.227 $ | +11.993.367 $ | +39,4 % | 1 |
| DEXCOM INC | DXCM | → 0 | Stark | 43.320.822 $ | +4.330.106 $ | +11,1 % | 1 | 38.990.716 $ | +27.441.868 $ | +237,6 % | 1 | ||||
| INSULET CORP | PODD | → 0 | Neutral | 32.852.760 $ | -7.185.286 $ | -17,9 % | 1 | 40.038.046 $ | +4.151.888 $ | +11,6 % | 1 | 35.886.158 $ | +2.657.853 $ | +8,0 % | 1 |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | → 0 | Neutral | 39.986.640 $ | +9.876.142 $ | +32,8 % | 1 | ||||||||
| KalVista Pharmaceuticals, Inc. | KALV | → 0 | 36.948.736 $ | +8.387.332 $ | +29,4 % | 1 | 28.561.404 $ | +7.429.067 $ | +35,2 % | 1 | |||||
| CVS HEALTH Corp | CVS | → 0 | Neutral | 27.816.317 $ | -7.912.507 $ | -22,1 % | 1 | 35.728.824 $ | +7.119.374 $ | +24,9 % | 1 | 28.609.450 $ | -7.108.877 $ | -19,9 % | 1 |
| ELI LILLY & Co | LLY | → 0 | Neutral | 31.838.758 $ | +24.208.758 $ | +317,3 % | 1 | ||||||||
| MCKESSON CORP | MCK | → 0 | Schwach | 29.821.643 $ | +7.771.806 $ | +35,2 % | 1 | ||||||||
| PTC THERAPEUTICS, INC. | PTCT | → 0 | Neutral | 29.388.829 $ | +17.221.632 $ | +141,5 % | 1 | ||||||||
| Xenon Pharmaceuticals Inc. | XENE | → 0 | Neutral | 28.902.585 $ | +21.992.058 $ | +318,2 % | 1 | ||||||||
| MBX Biosciences, Inc. | MBX | → 0 | Neutral | 27.933.054 $ | +14.400.234 $ | +106,4 % | 1 | ||||||||
| Kiniksa Pharmaceuticals International, plc | KNSA | → 0 | Neutral | 27.439.830 $ | +1.361.913 $ | +5,2 % | 1 | 26.077.917 $ | +12.552.932 $ | +92,8 % | 1 | ||||
| Arcus Biosciences, Inc. | RCUS | → 0 | Schwach | 26.077.118 $ | +2.995.332 $ | +13,0 % | 1 | ||||||||
| 336.162.320 $ | +58.258.136 $ | +78,7 % | 10 | 313.309.201 $ | +88.364.803 $ | +58,3 % | 9 | 220.997.992 $ | +78.001.017 $ | +30,6 % | 6 | ||||